Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report ; volume:16 ; number:1 ; day:2 ; month:8 ; year:2016 ; pages:1-4 ; date:12.2016
BMC cancer ; 16, Heft 1 (2.8.2016), 1-4, 12.2016

Creator: Choi, Seong Ji

Contributor: Kim, Hyo Jung
Kim, Jae Seon
Bak, Young-Tae
Kim, Jun Suk
SpringerLink (Online service)

DOI: 10.1186/s12885-016-2616-3

URN: urn:nbn:de:1111-20160804862

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Choi, Seong Ji
Kim, Hyo Jung
Kim, Jae Seon
Bak, Young-Tae
Kim, Jun Suk
SpringerLink (Online service)

Other Objects (12)

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature

Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature

Graffiti | Streetart

ZiPPi

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Abschnitt

Gastritis

Abschnitt

Gastritis

Abschnitt

Gastritis

Gastritis

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

Total Recall : Total recall

Total Recall : Total recall

Erlotinib in pancreatic cancer

Erlotinib in pancreatic cancer

Perhimpunan Peladjar Indonesia (PPI)

Archivale

Perhimpunan Peladjar Indonesia (PPI)

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature

Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature

Graffiti | Streetart

ZiPPi

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Abschnitt

Gastritis

Abschnitt

Gastritis

Abschnitt

Gastritis

Gastritis

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

Total Recall : Total recall

Total Recall : Total recall

Erlotinib in pancreatic cancer

Erlotinib in pancreatic cancer

Perhimpunan Peladjar Indonesia (PPI)

Archivale

Perhimpunan Peladjar Indonesia (PPI)

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature

Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature

Graffiti | Streetart

ZiPPi

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

Abschnitt

Gastritis

Abschnitt

Gastritis

Abschnitt

Gastritis

Gastritis

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

Total Recall : Total recall

Total Recall : Total recall

Erlotinib in pancreatic cancer

Erlotinib in pancreatic cancer

Perhimpunan Peladjar Indonesia (PPI)

Archivale

Perhimpunan Peladjar Indonesia (PPI)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.